Nutriband (NTRB) Projected to Post Earnings on Friday

Nutriband (NASDAQ:NTRB - Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Friday, May 30th. Analysts expect Nutriband to post earnings of ($0.13) per share and revenue of $0.71 million for the quarter.

Nutriband (NASDAQ:NTRB - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.06). The firm had revenue of $0.64 million during the quarter, compared to analysts' expectations of $0.71 million. Nutriband had a negative return on equity of 54.49% and a negative net margin of 338.51%. On average, analysts expect Nutriband to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nutriband Stock Up 6.9%

Shares of NTRB opened at $5.73 on Friday. The firm has a market cap of $63.91 million, a P/E ratio of -8.07 and a beta of 1.18. The stock has a 50 day simple moving average of $5.71 and a two-hundred day simple moving average of $5.66. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.96 and a quick ratio of 4.83. Nutriband has a 1 year low of $3.72 and a 1 year high of $11.78.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.